JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions

A Sarapultsev, E Gusev, M Komelkova, I Utepova… - Molecular …, 2023 - Springer
The Janus kinase-signal transducer and transcription activator pathway (JAK-STAT) serves
as a cornerstone in cellular signaling, regulating physiological and pathological processes …

JAK/STAT cytokine signaling at the crossroad of NK cell development and maturation

D Gotthardt, J Trifinopoulos, V Sexl… - Frontiers in …, 2019 - frontiersin.org
Natural Killer (NK) cells are cytotoxic lymphocytes of the innate immune system and play a
critical role in anti-viral and anti-tumor responses. NK cells develop in the bone marrow from …

Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine

ME Kavanagh, BD Horning, R Khattri, N Roy… - Nature chemical …, 2022 - nature.com
The Janus tyrosine kinase (JAK) family of non-receptor tyrosine kinases includes four
isoforms (JAK1, JAK2, JAK3, and TYK2) and is responsible for signal transduction …

Transcription factors associated with IL-15 cytokine signaling during NK cell development

X Wang, XY Zhao - Frontiers in Immunology, 2021 - frontiersin.org
Natural killer (NK) cells are lymphocytes primarily involved in innate immunity and possess
important functional properties in anti-viral and anti-tumor responses; thus, these cells have …

JAK/STAT signaling in stem cells and regeneration: from Drosophila to vertebrates

SC Herrera, EA Bach - Development, 2019 - journals.biologists.com
The JAK/STAT pathway is a conserved metazoan signaling system that transduces cues
from extracellular cytokines into transcriptional changes in the nucleus. JAK/STAT signaling …

Janus kinases to jakinibs: from basic insights to clinical practice

M Gadina, MT Le, DM Schwartz, O Silvennoinen… - …, 2019 - academic.oup.com
Cytokines are critical mediators of diverse immune and inflammatory diseases. Targeting
cytokines and cytokine receptors with biologics has revolutionized the treatment of many of …

JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders

W Vainchenker, E Leroy, L Gilles, C Marty… - …, 2018 - pmc.ncbi.nlm.nih.gov
JAK inhibitors have been developed following the discovery of the JAK2V617F in 2005 as
the driver mutation of the majority of non-BCR-ABL1 myeloproliferative neoplasms (MPNs) …

The impact of heterogeneity on single-cell sequencing

SL Goldman, M MacKay, E Afshinnekoo… - Frontiers in …, 2019 - frontiersin.org
The importance of diversity and cellular specialization is clear for many reasons, from
population-level diversification, to improved resiliency to unforeseen stresses, to unique …

Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling

DAC Fisher, CA Miner, EK Engle, H Hu, TB Collins… - Leukemia, 2019 - nature.com
The distinct clinical features of myelofibrosis (MF) have been attributed in part to
dysregulated inflammatory cytokine production. Circulating cytokine levels are elevated in …

T cell–derived interferon-γ programs stem cell death in immune-mediated intestinal damage

S Takashima, ML Martin, SA Jansen, Y Fu, J Bos… - Science …, 2019 - science.org
Despite the importance of intestinal stem cells (ISCs) for epithelial maintenance, there is
limited understanding of how immune-mediated damage affects ISCs and their niche. We …